No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
B-Lymphocytes / drug effects
-
Biological Therapy* / methods
-
Biological Therapy* / trends
-
Clinical Trials as Topic
-
Clinical Trials, Phase III as Topic
-
Cytokines / antagonists & inhibitors
-
Evidence-Based Medicine
-
Humans
-
Immunologic Factors / antagonists & inhibitors
-
Immunosuppressive Agents / therapeutic use
-
Interferon-alpha / antagonists & inhibitors
-
Interferon-gamma / antagonists & inhibitors
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / immunology*
-
Randomized Controlled Trials as Topic
-
Receptor, Anaphylatoxin C5a / antagonists & inhibitors
-
Sialic Acid Binding Ig-like Lectin 2 / therapeutic use
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal
-
Cytokines
-
Immunologic Factors
-
Immunosuppressive Agents
-
Interferon-alpha
-
Receptor, Anaphylatoxin C5a
-
Sialic Acid Binding Ig-like Lectin 2
-
Tumor Necrosis Factor-alpha
-
Interferon-gamma